29 participants
Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Immunogenicity of Single-Dose Subcutaneous Administration of MEDI-528
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2013-12-11
- Start Date:
- 2005-06-30
- Completion:
- 2006-04-30
Conditions
- Healthy
Interventions
- BIOLOGICAL